Choledocholithiasis: Should EUS Replace MRCP in Patients at Intermediate Risk?

Gastrointestinal Endoscopy - United States
doi 10.1016/j.gie.2017.07.034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparison of Optimized 3d-Space and 3d-Tse Sequences at 1.5T MRCP in the Diagnosis of Choledocholithiasis

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren
MedicineNuclear MedicineRadiologyImaging
2015English

What Is Personalized Medicine and What Should It Replace?

Nature Reviews Gastroenterology and Hepatology
HepatologyGastroenterology
2012English

Ultrahypofractionation Should Be a Standard of Care Option for Intermediate-Risk Prostate Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

The Cost-Effectiveness of Tavi in Intermediate Risk Patients in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Endoscopic Sphincterotomy With or Without Cholecystectomy for Choledocholithiasis in High Risk Surgical Patients: A Decision Analysis

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2005English

Dietary Cholesterol and Egg Yolk Should Be Avoided by Patients at Risk of Vascular Disease

Journal of Translational Internal Medicine
2016English

qSOFA Should Replace SIRS as the Screening Tool for Sepsis

Critical Care
Critical CareIntensive Care Medicine
2016English

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2015English

When to Remeasure Cardiovascular Risk in Untreated People at Low and Intermediate Risk: Observational Study

British Medical Journal
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy